Gujarat Terce Laboratories Limited (BOM:524314)
India
· Delayed Price · Currency is INR 38.53
+0.22 (0.57%)
At close: Mar 10, 2026
BOM:524314 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 483.98 | 501.95 | 479.75 | 467.83 | 401.34 | 251.78 | Upgrade
|
| Revenue Growth (YoY) | -1.52% | 4.63% | 2.55% | 16.57% | 59.40% | -32.94% | Upgrade
|
| Cost of Revenue | 190.01 | 191.63 | 177.53 | 193.8 | 154.49 | 100.54 | Upgrade
|
| Gross Profit | 293.97 | 310.32 | 302.22 | 274.02 | 246.85 | 151.24 | Upgrade
|
| Selling, General & Admin | 194.25 | 195.01 | 190.32 | 175.62 | 182.22 | 142.29 | Upgrade
|
| Other Operating Expenses | 59.12 | 76.49 | 99.23 | 120 | 53.45 | 34.84 | Upgrade
|
| Operating Expenses | 257.28 | 275.34 | 293.23 | 299.26 | 238.43 | 178.9 | Upgrade
|
| Operating Income | 36.68 | 34.98 | 8.99 | -25.24 | 8.42 | -27.66 | Upgrade
|
| Interest Expense | -1.69 | -3.62 | -6.28 | -6.68 | -3.33 | -3.44 | Upgrade
|
| Interest & Investment Income | 2.56 | 2.56 | 3.03 | 3.55 | 2.88 | 3.02 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.28 | -0.13 | -0.3 | -0.53 | -0.68 | -0.47 | Upgrade
|
| EBT Excluding Unusual Items | 37.83 | 33.79 | 5.44 | -28.9 | 7.28 | -28.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.11 | 0.11 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.04 | - | -1.78 | Upgrade
|
| Pretax Income | 37.95 | 33.9 | 5.44 | -28.94 | 7.47 | -25.32 | Upgrade
|
| Income Tax Expense | 50.75 | 43.69 | 3.01 | -12.22 | -1.26 | -0.11 | Upgrade
|
| Net Income | -12.81 | -9.79 | 2.44 | -16.72 | 8.72 | -25.2 | Upgrade
|
| Net Income to Common | -12.81 | -9.79 | 2.44 | -16.72 | 8.72 | -25.2 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 7 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 7 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | 3.44% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -1.66 | -1.32 | 0.33 | -2.25 | 1.18 | -3.40 | Upgrade
|
| EPS (Diluted) | -1.66 | -1.32 | 0.33 | -2.25 | 1.18 | -3.40 | Upgrade
|
| Free Cash Flow | - | 30.59 | 25.26 | -0.36 | -25.57 | -6.68 | Upgrade
|
| Free Cash Flow Per Share | - | 4.12 | 3.40 | -0.05 | -3.45 | -0.90 | Upgrade
|
| Gross Margin | 60.74% | 61.82% | 63.00% | 58.57% | 61.51% | 60.07% | Upgrade
|
| Operating Margin | 7.58% | 6.97% | 1.87% | -5.39% | 2.10% | -10.99% | Upgrade
|
| Profit Margin | -2.65% | -1.95% | 0.51% | -3.57% | 2.17% | -10.01% | Upgrade
|
| Free Cash Flow Margin | - | 6.09% | 5.27% | -0.08% | -6.37% | -2.65% | Upgrade
|
| EBITDA | 40.66 | 38.83 | 12.67 | -21.59 | 11.18 | -25.9 | Upgrade
|
| EBITDA Margin | 8.40% | 7.74% | 2.64% | -4.61% | 2.78% | -10.29% | Upgrade
|
| D&A For EBITDA | 3.97 | 3.85 | 3.68 | 3.65 | 2.76 | 1.76 | Upgrade
|
| EBIT | 36.68 | 34.98 | 8.99 | -25.24 | 8.42 | -27.66 | Upgrade
|
| EBIT Margin | 7.58% | 6.97% | 1.87% | -5.39% | 2.10% | -10.99% | Upgrade
|
| Effective Tax Rate | 133.75% | 128.87% | 55.24% | - | - | - | Upgrade
|
| Revenue as Reported | 487.47 | 505.03 | 482.96 | 471.37 | 404.4 | 259.8 | Upgrade
|
| Advertising Expenses | - | 31.18 | 30.1 | 25.85 | 21.85 | 10.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.